Study of the effectiveness of craniotomy on patients with acute post-traumatic brain swelling after severe traumatic brain injury
| ISRCTN | ISRCTN14110527 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN14110527 |
| Protocol serial number | 2008R40G2150132 |
| Sponsor | Zhejiang and Hangzhou Health Department (China) |
| Funder | Zhejiang and Hangzhou Health Department (China) - Scientific Research Fund (ref: 2009) |
- Submission date
- 10/02/2009
- Registration date
- 03/04/2009
- Last edited
- 04/05/2010
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Injury, Occupational Diseases, Poisoning
Plain English summary of protocol
Not provided at time of registration
Contact information
Scientific
126 Wengzhou Road
Department of Neurosurgery
Hangzhou Second Hospital
College of Medicine
Hangzhou Normal University
Hangzhou
310015
China
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Single-centre prospective randomised controlled double-blind trial |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | Study of the effectiveness of craniotomy (Decompressive Craniectomy [DC] or routine temporoparietal craniectomy) on patients with Acute post-traumatic Brain Swelling after severe traumatic brain injury: a single-centre, prospective randomised, controlled, double-blind trial |
| Study acronym | DCABS |
| Study objectives | The aim of the present clinical study was to assess the efficacy of craniotomy, decompressive craniectomy (DC) or routine temporoparietal craniectomy, on patients with acute post-traumatic brain swelling (BS). We assume that DC has superior effectiveness on patients with acute BS after severe traumatic brain injury. |
| Ethics approval(s) | Institutional Review Board and the ethical committees of Clinical Medical College of Hangzhou gave approval on the 1st September 2002 (ref: 200203) |
| Health condition(s) or problem(s) studied | Acute post-traumatic brain swelling |
| Intervention | Based on the guidelines for the management of severe head injury set forth by the Joint Section on Neurotrauma and Critical Care of the Brain Trauma Foundation and the American Association of Neurological Surgeons, all patients underwent lateral craniotomy within 24 hours after injury and other medical management such as dehydration with mannitol (average amount received in subsequent 6-hour period was 20% mannitol 125 ml) and routine pharmacological or physical measures adopted to maintain normal body temperature after diagnosis of post-traumatic BS accordingly. The surgery mode of DC was elective at the frontoparietotemporal region, based on the lesion location and midline shift determined by CT scans. Briefly, the bone window was about 15 cm in diameter with duraplasty using expanded dura substitute when necessary. The anterior was frontal to the midpupillary lines, and the posterior line was about 3 - 4 cm posterior to the external acustic meatus. The superior line was 2 cm of the lateral edge of the superior sagittal sinus, and the inferior line was extended below the level of the zygomatic arch, so that the frontal and temporal base could be explored. Durotomy was performed over the entire region of bony decompression as a stellate shape. Cranioplasty was performed after 3 months. Post-operative therapy was similar with those previously described, which included keeping respiratory tract unobstructed (with assisted ventilation to ensure arterial O2 saturation (SaO2) greater than or equal to 95% against hypoxia and partial pressure of carbon dioxide in arterial blood (PaCO2) maintained near 40mm Hg at 37°C), intubations if necessary, controlling the blood glucose level and body temperature and balancing water and electrolyte, dehydration and diuresis, homeostasis balanced, anti-infection with sensitive antibiotics and so on. The control group received the unilateral routine temporoparietal craniectomy and the operation site depended on the location of injury and midline shift accordingly. The bone window diametered about 8 cm and the dura mater was also fixed at the edge with duraplasty, and the bone was re-implanted after 3 - 6 months. In the routine craniotomy group, post-operative treatment was similar with those in the DC group. |
| Intervention type | Other |
| Primary outcome measure(s) |
1. Intracranial pressure (ICP) - continuous recording of ICP was applied in all patients for 96 hours with the ICP monitor system (Camino-MPM1, Integra LifeSciences CO, USA). A cranial hole was drilled, if necessary, and the drainage catheter was induced 5 cm or so into right lateral ventricles via the level of the anterior horn. The intraventricular (intracerebral) pressure probe (Camino-110-4B) was placed at the level of foramen of Momro during craniotomy. |
| Key secondary outcome measure(s) |
1. Vital signs (temperature, heart rate, breathing rate and blood pressure), arterial oxygen saturation with the multiple monitor (Model NO: 90309, Space Lab, Medical. Inc. USA) recorded every 12 hours for 7 days after craniotomy |
| Completion date | 01/12/2008 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Sex | All |
| Target sample size at registration | 80 |
| Key inclusion criteria | 1. Aged from 18 to 65 years, either sex 2. A history of traumatic brain injury 3. Glasgow Coma Score (GCS) less than or equal to 8 at admission 4. Computed tomography (CT) scans: swollen hemisphere (with midline shift greater than 5 mm, compressed basal cisterns) within 24 hours after trauma |
| Key exclusion criteria | 1. Patients younger than 19 or older than 65 years 2. Multiply-injured patients without sufficient resuscitation 3. With any previous disabling neurological disease 4. Intracerebral haematoma of more than 3 cm in diameter 5. Spinal cord injury 6. Penetrating brain injury 7. Fixed dilated pupils and GCS score of 3 with no chance of survival |
| Date of first enrolment | 01/01/2003 |
| Date of final enrolment | 01/12/2008 |
Locations
Countries of recruitment
- China
Study participating centre
310015
China
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 01/11/2009 | Yes | No | |
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |